DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RENVELA

« Back to Dashboard

Clinical Trials for Renvela

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00785629	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	DaVita Dialysis	N/A	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Fresenius Medical Care North America	N/A	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Genzyme, a Sanofi Company	N/A	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Novartis Pharmaceuticals	N/A	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Shire	N/A	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Denver Nephrologists, P.C.	N/A	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00853242	Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis	Completed	Genzyme, a Sanofi Company	Phase 2	The purpose of this clinical study is to compare the effects of Genz-644470 with the effects of placebo and sevelamer carbonate (Renvela®) on the reduction of serum phosphorus in hyperphosphatemic chronic kidney disease participants on hemodialysis.

Clinical Trial Conditions for Renvela

Condition Name

Condition Name for Renvela
Intervention	Trials
Chronic Kidney Disease	6
Hyperphosphatemia	4
Kidney Failure, Chronic	2
Healthy	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Renvela
Intervention	Trials
Kidney Diseases	11
Renal Insufficiency, Chronic	9
Kidney Failure, Chronic	6
Hyperphosphatemia	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Renvela

Trials by Country

Trials by Country for Renvela
Location	Trials
United States	82
Puerto Rico	3
Italy	2
Germany	1
Spain	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Renvela
Location	Trials
New York	7
California	6
Texas	6
Colorado	5
Illinois	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Renvela

Clinical Trial Phase

Clinical Trial Phase for Renvela
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	5
Phase 2	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Renvela
Clinical Trial Phase	Trials
Completed	14
Recruiting	4
Terminated	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Renvela

Sponsor Name

Sponsor Name for Renvela
Sponsor	Trials
Genzyme, a Sanofi Company	7
Shire	3
Fresenius Medical Care North America	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Renvela
Sponsor	Trials
Industry	20
Other	15
NIH	1

Export unavailable in trial.
Subscribe for complete access.